key: cord-0691468-fea0k5by
authors: Perkins, Sara; Cohen, Jeffrey M.; Nelson, Caroline A.; Bunick, Christopher G.
title: Teledermatology in the Era of COVID-19: Experience of an Academic Department of Dermatology
date: 2020-04-17
journal: J Am Acad Dermatol
DOI: 10.1016/j.jaad.2020.04.048
sha: 457879b74abfa6333ae5096b5ec5999a76679452
doc_id: 691468
cord_uid: fea0k5by

nan

We read with great interest the articles by Chen et al 1 and Price et al 2 outlining an 24 approach to telemedicine implementation during the COVID-19 pandemic. However, the 25 feasibility of these theoretical solutions has yet to be definitively and widely shown. 26

Herein we report the successful transition of the ambulatory practice in the Department 27 of Dermatology at the Yale School of Medicine from a completely office-based practice 28

to a primarily teledermatolology model over three weeks. 29

Our department is comprised of four main clinical sites in the greater New Haven, CT 31 area. We have 24 full-time clinical faculty serving approximately 1200 patients each 32

week. In an effort to minimize risk of contagion while preserving scarce resources 33 including personal protective equipment, we temporarily closed our offices on March 16, 34 2020 3,4 . Prior to this pandemic, our department had no teledermatology services. Every patient with an existing appointment was called using a call-script and offered a 44 live interactive telemedicine visit. Established patients who were unable or unwilling to 45 perform a video visit were offered the option of a telephone visit. A medical dermatology advisory panel consisting of five faculty members was established to triage urgent and 47 emergent cases first via teledermatology to determine the need for in-person evaluation. 48

On a case-by-case basis, the panel requested input from three panel liaisons with 49 expertise in surgical dermatology, pediatric dermatology, and dermatopathology. 50 51 Three of four sites successfully completed telemedicine visits within the first day (Fig.  52   1b) . Within the first week, offices completed 225 teledermatology visits while in-person 53 visits were essentially eliminated. Telemedicine visits increased 191% in the second 54

week and nearly 500 visits were completed in the third week alone. Over three weeks 55 we completed 1148 teledermatology visits and current telemedicine volume is 41% of 56 our pre-crisis volume. Importantly, there were fewer than five in-person visits. 57 58 Each site served patients of all ages with a variety of dermatologic conditions. We found 59 that certain conditions (acne, psoriasis, eczema, rashes, rosacea, and lesions of 60 concern) were particularly amenable to teledermatology, while other visit types (total 61 body skin examinations) were not reliably accomplished through this modality. We 62 identified that a hybrid of "store-and-forward" and "live interactive" approaches often 63 enabled better evaluation of patient concerns, such as "tele-triaging" individual lesions. Medicine. Due to the COVID-19 pandemic, in-person visits were dramatically reduced 98

while the implementation of telemedicine serves a growing number of patients. 99

What are we doing in the dermatology outpatient 82 department amidst the raging of the 2019 novel coronavirus? J Am Acad 83 Dermatol

Strategic dermatology clinical 85 operations during COVID-19 pandemic

Dermatology practices as vectors for 87 COVID-19 transmission: a call for immediate cessation of non-emergent 88 dermatology visits